Published in Biochim Biophys Acta on November 10, 1999
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell (2002) 5.06
Iron deprivation in cancer--potential therapeutic implications. Nutrients (2013) 0.98
Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World J Hepatol (2015) 0.95
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal (2013) 0.94
Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire. J Pediatr Hematol Oncol (2010) 0.94
Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leukemia (2010) 0.92
Proteomic analysis reveals that iron availability alters the metabolic status of the pathogenic fungus Paracoccidioides brasiliensis. PLoS One (2011) 0.90
Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression. Biochem J (2002) 0.89
Involvement of fumarase C and NADH oxidase in metabolic adaptation of Pseudomonas fluorescens cells evoked by aluminum and gallium toxicity. Appl Environ Microbiol (2008) 0.88
Metabolomic analysis of cerebrospinal fluid indicates iron deficiency compromises cerebral energy metabolism in the infant monkey. Neurochem Res (2012) 0.80
Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis. mSphere (2016) 0.75
Iron Content Affects Lipogenic Gene Expression in the Muscle of Nelore Beef Cattle. PLoS One (2016) 0.75
Urine metabolomic profiling of children with respiratory tract infections in the emergency department: a pilot study. BMC Infect Dis (2016) 0.75
"Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch (2017) 0.75
Altered Mitochondrial Signalling and Metabolism in Cancer. Front Oncol (2017) 0.75
Phlebotomy-induced anemia alters hippocampal neurochemistry in neonatal mice. Pediatr Res (2015) 0.75
Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation. Wien Med Wochenschr (2016) 0.75
An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. Elife (2016) 0.75
Catecholamine stress hormones regulate cellular iron homeostasis by a posttranscriptional mechanism mediated by iron regulatory protein: implication in energy homeostasis. J Biol Chem (2015) 0.75
Intracellular iron and heme trafficking and metabolism in developing erythroblasts. Metallomics (2017) 0.75
Antioxidants Mediate Both Iron Homeostasis and Oxidative Stress. Nutrients (2017) 0.75
Cellular citrate levels establish a regulatory link between energy metabolism and the hepatic iron hormone hepcidin. J Mol Med (Berl) (2017) 0.75
Ironing Out the Unconventional Mechanisms of Iron Acquisition and Gene Regulation in Chlamydia. Front Cell Infect Microbiol (2017) 0.75
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol (1999) 10.86
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia (2007) 3.13
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol (1992) 3.00
Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet (1999) 2.68
Great ape DNA sequences reveal a reduced diversity and an expansion in humans. Nat Genet (2001) 2.62
Pattern of nucleotide substitution and rate heterogeneity in the hypervariable regions I and II of human mtDNA. Genetics (1999) 2.42
mtDNA sequence diversity in Africa. Am J Hum Genet (1996) 2.28
Melanesian origin of Polynesian Y chromosomes. Curr Biol (2000) 2.27
Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry (1985) 2.17
Iron, anaemia, and inflammatory bowel diseases. Gut (2004) 2.03
Effect of long-term treatment of hyperactive children with methylphenidate. Can Med Assoc J (1975) 1.78
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology (2001) 1.68
Independent histories of human Y chromosomes from Melanesia and Australia. Am J Hum Genet (2000) 1.58
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors. J Clin Oncol (1999) 1.56
Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens (2008) 1.54
Assessing menstrual cycles with urinary hormone assays. Am J Physiol Endocrinol Metab (2002) 1.46
Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study. Cancer J Sci Am (1997) 1.45
The hyper-IgE syndrome. Two cases and review of the literature. Int J Dermatol (2001) 1.44
A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium. Ann Oncol (1996) 1.43
The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci (1992) 1.42
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut (2002) 1.41
H CLASSES OF HOLOMORPHIC FUNCTIONS IN TUBE DOMAINS. Proc Natl Acad Sci U S A (1964) 1.38
Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol (1993) 1.36
Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem (1993) 1.35
A respirometer for investigating oxidative cell metabolism: toward optimization of respiratory studies. Anal Biochem (1994) 1.32
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion. J Clin Oncol (1993) 1.32
Solubilization and reconstitution of the membrane-bound carotenogenic enzymes from daffodil chromoplasts. Eur J Biochem (1985) 1.31
High-resolution respirometry--a modern tool in aging research. Exp Gerontol (2005) 1.27
Neural networks as a tool for utilizing laboratory information: comparison with linear discriminant analysis and with classification and regression trees. Proc Natl Acad Sci U S A (1991) 1.27
Estimating the age of the common ancestor of men from the ZFY intron. Science (1996) 1.23
Parenchymal sparing surgery in patients with hereditary renal cell carcinoma. J Urol (1995) 1.21
Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J Immunol (1999) 1.21
Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol Cell Biol (1996) 1.20
Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J Infect Dis (2001) 1.19
[Gas chromatographic examinations of sebaceous gland lipids. I. Total lipid determination]. Arch Klin Exp Dermatol (1970) 1.18
Young adult outcome of hyperactive children who received long-term stimulant treatment. J Am Acad Child Psychiatry (1984) 1.16
Comparison of the effects of chlorpromazine, dextroamphetamine and methylphenidate on the behaviour and intellectual functioning of hyperactive children. Can Med Assoc J (1971) 1.14
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group. J Clin Oncol (1993) 1.12
Anaerobic dormancy quantified in artemia embryos: a calorimetric test of the control mechanism. Science (1988) 1.11
Severe anaemia in Zambian children with Plasmodium falciparum malaria. Trop Med Int Health (2000) 1.08
Ralstonia pickettii-innocent bystander or a potential threat? Clin Microbiol Infect (2006) 1.08
Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol (1997) 1.08
Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab (2008) 1.07
Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem (2001) 1.07
Utilisation of locally delivered doxycycline in non-surgical treatment of chronic periodontitis. A comparative multi-centre trial of 2 treatment approaches. J Clin Periodontol (2001) 1.07
Size-selective preparation of inorganic fibers for biological experiments. Am Ind Hyg Assoc J (1979) 1.07
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery. Acta Physiol (Oxf) (2014) 1.06
Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol (2002) 1.05
Imported malaria: six cases of severe Plasmodium falciparum infection in Innsbruck, Austria, within a period of five weeks (February/March 1999) Wien Klin Wochenschr (2000) 1.05
Prolonged macrophage activation and persistent anaemia in children with complicated malaria. Trop Med Int Health (1998) 1.05
The hyperactive child in elementary school: a 5 year, controlled, followup. Except Child (1971) 1.05
Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology (2001) 1.04
A 5-year follow-up study of 91 hyperactive school children. J Am Acad Child Psychiatry (1972) 1.04
Studies on the hyperactive child. 8. Five-year follow-up. Arch Gen Psychiatry (1971) 1.03
Tryptophan degradation to control T-cell responsiveness. Immunol Today (2000) 1.03
Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokines. Med Oncol (2001) 1.03
A scanning microscope study of the topography of HeLa cells. Cancer Res (1974) 1.03
Hyperactives as young adults: a controlled prospective ten-year follow-up of 75 children. Arch Gen Psychiatry (1979) 1.01
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days. Anticancer Drugs (1992) 1.01
Attention in hyperactive children and the effect of methylphenidate (ritalin). J Child Psychol Psychiatry (1971) 1.01
Lectin target cells in human central nervous system and the pituitary gland. Histochemistry (1984) 1.01
Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection. Curr Drug Metab (2007) 1.01
Oxygen dependence of respiration in coupled and uncoupled endothelial cells. Am J Physiol (1996) 1.01
Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans. Gastroenterology (1984) 1.00
Effects of the Aspergillus fumigatus siderophore systems on the regulation of macrophage immune effector pathways and iron homeostasis. Immunobiology (2008) 1.00
ADHD in parents. J Am Acad Child Adolesc Psychiatry (2000) 0.99
Controlled micromanipulation of human sperm in three dimensions with an infrared laser optical trap: effect on sperm velocity. Fertil Steril (1992) 0.99
IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int Immunol (2000) 0.99
Nitric oxide and the post-transcriptional control of cellular iron traffic. Trends Cell Biol (1994) 0.99
Studies on the hyperactive child. V. The effects of dextroamphetamine and chlorpromazine on behaviour and intellectual functioning. J Child Psychol Psychiatry (1968) 0.99
Ca2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Biochem J (1993) 0.98
A peptide prodrug approach for improving bisphosphonate oral absorption. J Med Chem (2000) 0.98
Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet (1991) 0.98
Quality of life and immune activation in patients with HIV-infection. Brain Behav Immun (2008) 0.97
Intracerebral radio stimulation and recording in completely free patients. J Nerv Ment Dis (1968) 0.97
Interleukin-2-based therapy for metastatic renal cell cancer: the Cytokine Working Group experience, 1989-1997. Cancer J Sci Am (1997) 0.97
Subcellular distribution of a factor inactivating tyrosine aminotransferase. Study of its mechanism and relationship to different forms of the enzyme. Eur J Biochem (1978) 0.96
Microcalorimetric measurement of reversible metabolic suppression induced by anoxia in isolated hepatocytes. Am J Physiol (1993) 0.96
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers. Pharmacol Res (2009) 0.96
Hearing and middle ear function in osteogenesis imperfecta. JAMA (1982) 0.96
Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol (1993) 0.95
Nonclostridial gas gangrene. J Foot Surg (1990) 0.95
Markers of inflammation in children with severe malarial anaemia. Trop Med Int Health (2000) 0.95
Growth and cardiovascular measures in hyperactive individuals as young adults and in matched normal controls. Can Med Assoc J (1978) 0.95
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel. J Clin Oncol (2001) 0.95
Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency. Arch Immunol Ther Exp (Warsz) (2000) 0.95
Studies on the hyperactive child. 3. The effect of chlorpromazine upon behavior and learning ability. J Am Acad Child Psychiatry (1966) 0.95
Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study. Clin Cancer Res (2000) 0.94
Hyperactives as young adults: preliminary report. Can Med Assoc J (1976) 0.94
High resolution respirometry of permeabilized skeletal muscle fibers in the diagnosis of neuromuscular disorders. Mol Cell Biochem (1997) 0.94
A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies. Clin Cancer Res (1998) 0.94
Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br J Haematol (2000) 0.93
The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method. Aliment Pharmacol Ther (2013) 0.93
Iron chelation therapy for malaria: a review. Pharmacol Ther (1999) 0.93
Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc Res (2001) 0.93
Luteal progesterone relates to histological endometrial maturation in fertile women. J Clin Endocrinol Metab (2000) 0.93
Hyperactives as young adults: past and current substance abuse and antisocial behavior. Am J Orthopsychiatry (1984) 0.92
Long-term sequelae of HFE deletion in C57BL/6 x 129/O1a mice, an animal model for hereditary haemochromatosis. Eur J Clin Invest (2002) 0.92
Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr (1994) 0.92